On Invalid Date, 2seventy Bio (NASDAQ: TSVT) reported Q4 2023 earnings per share (EPS) of -$1.11, up 141.3% year over year. Total 2seventy Bio earnings for the quarter were -$56.82 million. In the same quarter last year, 2seventy Bio's earnings per share (EPS) was -$0.46.
As of Q2 2024, 2seventy Bio's earnings has grown year over year. 2seventy Bio's earnings in the past year totalled -$217.57 million.
What is TSVT's earnings date?
2seventy Bio's earnings date is Invalid Date. Add TSVT to your watchlist to be reminded of TSVT's next earnings announcement.
What was TSVT's revenue last quarter?
On Invalid Date, 2seventy Bio (NASDAQ: TSVT) reported Q4 2023 revenue of $10.68 million up 80.98% year over year. In the same quarter last year, 2seventy Bio's revenue was $56.18 million.
What was TSVT's revenue growth in the past year?
As of Q2 2024, 2seventy Bio's revenue has grown 9.72% year over year. This is 138.69 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. 2seventy Bio's revenue in the past year totalled $100.39 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.